Treatment of aggressive recurrent meningiomas: spinning towards peptide receptor radionuclide therapy
出版年份 2018 全文链接
标题
Treatment of aggressive recurrent meningiomas: spinning towards peptide receptor radionuclide therapy
作者
关键词
-
出版物
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-12-14
DOI
10.1007/s00259-018-4221-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lung Metastases of Intracranial Atypical Meningioma Diagnosed on Posttherapeutic Imaging After 177Lu-DOTATATE Therapy
- (2018) Philipp Backhaus et al. CLINICAL NUCLEAR MEDICINE
- Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning
- (2018) Marta Cremonesi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
- (2017) Anna Sundlöv et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
- (2017) Michela Del Prete et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review
- (2017) Thomas Graillon et al. JOURNAL OF NEUROSURGERY
- PET imaging in patients with meningioma—report of the RANO/PET Group
- (2017) Norbert Galldiks et al. NEURO-ONCOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- EANO guidelines for the diagnosis and treatment of meningiomas
- (2016) Roland Goldbrunner et al. LANCET ONCOLOGY
- 68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?
- (2016) Michael Sommerauer et al. NEURO-ONCOLOGY
- Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to68Ga-DOTATATE/-TOC uptake
- (2016) Katharina Seystahl et al. NEURO-ONCOLOGY
- 90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas
- (2015) K. Gerster-Gillieron et al. JOURNAL OF NUCLEAR MEDICINE
- Somatostatin Receptor-Targeted Radiopeptide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial
- (2015) N. Marincek et al. JOURNAL OF NUCLEAR MEDICINE
- Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review
- (2014) T. Kaley et al. NEURO-ONCOLOGY
- Meningiomas: A Comparative Study of 68Ga-DOTATOC, 68Ga-DOTANOC and 68Ga-DOTATATE for Molecular Imaging in Mice
- (2014) María Luisa Soto-Montenegro et al. PLoS One
- Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment
- (2012) M. Sandstrom et al. JOURNAL OF NUCLEAR MEDICINE
- Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma
- (2012) Michael C Kreissl et al. Radiation Oncology
- Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report
- (2011) Amir Sabet et al. Radiation Oncology
- Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma
- (2009) Mirco Bartolomei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started